Part 2: Podcast Interview of Leadership Team
Published 12/16/2022
In Part 2 the ThinkGenetic leadership team talks a little more about the company's business side. Learn More
Digitally transforming the undiagnosed patient identification market for rare and genetic conditions
Welcome to ThinkGenetic
ThinkGenetic's goal is to speed time to diagnosis for genetic and rare conditions and reduce the chances of diagnostic error - two things that can make a significant difference for millions of people around the world. ThinkGenetic utilizes Natural Language Processing, statistical modeling, and proprietary algorithms to identify individuals at-risk of having a genetic disease. The ThinkGenetic experts have developed two validated solutions to identify at-risk patients: one through electronic health records, FindEHR, and the consumer-focused tool, SymptomMatcher.
Our validated products are sensitive and specific enough to flag patients at increased risk to have a genetic diagnosis and include targeted information to educate providers quickly and efficiently about available sponsored testing, enrolling clinical trials, referral to genetics, and FDA approved treatments. De-identified, HIPAA-compliant, summary data can then be shared with our pharma clients to supplement their sales and marketing efforts while benefiting the patients and assisting their clinicians to explore possible genetic diagnoses.
ThinkGenetic News
Celebrating PKU Awareness
Published 12/15/2022
Celebrate PKU awareness by learning about PKU and trying PKU-friendly recipes this holiday season. Learn More
Announcing Addition of Rene Matz
Published 11/10/2022
New Vice President of Business Development to Expand Global Adoption of Product Line Learn More
Guardian Research Network Collaboration
Published 07/28/2022
Overlapping missions to support healthcare providers and shorten time to diagnosis. Learn More
